568 related articles for article (PubMed ID: 28433332)
1. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
[TBL] [Abstract][Full Text] [Related]
2. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
[TBL] [Abstract][Full Text] [Related]
3. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
4. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
[TBL] [Abstract][Full Text] [Related]
5. Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women results from a Swedish nationwide study.
Sigvant B; Hasvold P; Thuresson M; Jernberg T; Janzon M; Nordanstig J
Eur J Prev Cardiol; 2021 Oct; 28(13):1426-1434. PubMed ID: 34695221
[TBL] [Abstract][Full Text] [Related]
6. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
[TBL] [Abstract][Full Text] [Related]
8. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
[TBL] [Abstract][Full Text] [Related]
9. Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.
Sartipy F; Sigvant B; Lundin F; Wahlberg E
Eur J Vasc Endovasc Surg; 2018 Apr; 55(4):529-536. PubMed ID: 29478910
[TBL] [Abstract][Full Text] [Related]
10. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
[TBL] [Abstract][Full Text] [Related]
11. A prospective study about impact of renal dysfunction and morbidity and mortality on cardiovascular events after ischemic stroke.
Penko M; Hojs Fabjan T; Bevc S; Kanič V; Hojs R
Cardiol J; 2014; 21(2):163-9. PubMed ID: 23799556
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
Zhang Q; Wang A; Zhang S; Li N; Chen S; Zhang Y; Zhou Y; Wu S; Zhao X
Atherosclerosis; 2017 Jul; 262():1-7. PubMed ID: 28463782
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of vorapaxar as approved for clinical use in the United States.
Magnani G; Bonaca MP; Braunwald E; Dalby AJ; Fox KA; Murphy SA; Nicolau JC; Oude Ophuis T; Scirica BM; Spinar J; Theroux P; Morrow DA
J Am Heart Assoc; 2015 Mar; 4(3):e001505. PubMed ID: 25792124
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
15. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
Beatty AL; Ku IA; Bibbins-Domingo K; Christenson RH; DeFilippi CR; Ganz P; Ix JH; Lloyd-Jones D; Omland T; Sabatine MS; Schiller NB; Shlipak MG; Skali H; Takeuchi M; Vittinghoff E; Whooley MA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26150476
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK.
Cea Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
Eur J Prev Cardiol; 2017 Dec; 24(18):1927-1937. PubMed ID: 29053020
[TBL] [Abstract][Full Text] [Related]
17. Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.
Inohara T; Pieper K; Wojdyla DM; Patel MR; Jones WS; Tricoci P; Mahaffey KW; James SK; Alexander JH; Lopes RD; Wallentin L; Ohman EM; Roe MT; Vemulapalli S
Am Heart J; 2018 Jul; 201():25-32. PubMed ID: 29910052
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.
Nehler MR; Duval S; Diao L; Annex BH; Hiatt WR; Rogers K; Zakharyan A; Hirsch AT
J Vasc Surg; 2014 Sep; 60(3):686-95.e2. PubMed ID: 24820900
[TBL] [Abstract][Full Text] [Related]
19. Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study.
Hasvold P; Nordanstig J; Kragsterman B; Kristensen T; Falkenberg M; Johansson S; Thuresson M; Sigvant B
Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):10-17. PubMed ID: 28950310
[TBL] [Abstract][Full Text] [Related]
20. Male Sex Associated with Increased Long-term Cardiovascular Mortality after Peripheral Vascular Surgery for Atherosclerosis Despite Optimal Medical Treatment.
Budtz-Lilly JW; Petersen CN; Pedersen TF; Eldrup N
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):767-73. PubMed ID: 26371415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
